https://www.selleckchem.com/pr....oducts/halofuginone.
To evaluate the inter-rater agreement of chest X-ray (CXR) findings in coronavirus disease 2019 (COVID-19) and to determine the value of initial CXR along with demographic, clinical, and laboratory data at emergency department (ED) presentation for predicting mortality and the need for ventilatory support. A total of 340 COVID-19 patients who underwent CXR in the ED setting (March 1-13, 202 were retrospectively included. Two reviewers independently assessed CXR abnormalities, including ground-glass opacities (GGOs) and consolidat
Like
Comment
Share
